Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs

Journal of Clinical Microbiology

Volumn 39, Issue 3, 2001, Pages 1008-1016

  Van der Pol, B ^a   Ferrero, D V ^a   Buck Barrington, L ^a   Hook III, E ^a   Lenderman, C ^a   Quinn, T ^a   Gaydos, C A ^a   Lovchik, J ^a   Schachter, J ^a   Moncada, J ^a   Hall, G ^a   Tuohy, M J ^a   Jones, R B ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FAMILY PLANNING; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; URETHRA; URINALYSIS; UTERINE CERVIX;

CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CULTURE MEDIA; DNA, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URETHRA; URINE;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE;

EID: 0035102713     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.3.1008-1016.2001     Document Type: Article

References (32)

1. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin
2. "But Doctor, I'm celibate" the potential for, sources, and implications of false-positive (and -negative) results of tests for Chlamydia trachomatis
3. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States
4. Performance of the Gen-Probe amplified Chlamydia trachomatis assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics
5. Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine
6. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996
7. Reproducibility problems with the Abbott Laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae
8. Control of Chlamydia trachomatis infections in female army recruits: Cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease
9. Urine screening for gonococcal and chlamydial infections at community-based organizations in a high-morbidity area
10. Effect of differences in specimen processing and passage technique on recovery of Chlamydia trachomatis
11. Programmes to reduce pelvic inflammatory disease - The Swedish experience
12. Declining prevalence of chlamydial infection among adolescent girls
13. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: A performance review with clinical and public health considerations
14. Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures
15. Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbe TecET
16. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction and transcription mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity
17. Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens
18. Surveillance of sexually transmitted diseases in France: Recent trends and incidence
19. Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: Performance of the LCx and COBAS Amplicor tests with urine specimens
20. Genital chlamydia infections in sexually active female adolescents: Do we really need to screen everyone?
21. Reproducibility of the Roche Amplicor polymerase chain reaction assay for detection of infection by Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens
22. Chlamydia trachomatis: Impact on human reproduction
23. Laboratory to laboratory variation in Chlamydia trachomatis culture practices
24. An internal control for routine diagnostic PCR: Design, properties and effect on clinical performance
25. Culture and isolation of Chlamydia trachomatis
26. DFA ,EIA, PCR, LCR and other technologies: What tests should be used for diagnosis of chlamydial infections?
27. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
28. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?
29. Epidemiology of genital Chlamydia trachomatis infections in England and Wales
30. Multicenter evaluation of the Amplicor and automated Cobas Amplicor CT/NG tests for the detection of Chlamydia trachomatis
31. Declining trends in some sexually transmitted diseases in Belgium between 1983 and 1989